Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by StockReddyon Apr 05, 2021 6:45pm
71 Views
Post# 32939127

RE:RE:Count down for Ryplazim FDA Decision

RE:RE:Count down for Ryplazim FDA DecisionThey have stopped burning and waiting for the FDA decision. The truth is LMNL do not have enough money to operate and they will reopen after FDA approval. 

Why FDA approved a plasma collection plant in USA? My guess is FDA is going to give green light.

This is a good bet than before; it was overvalued in 2015-2018 and now it is undervalued. $20-30 is possible if FDA approves and my average is $12.

IMHO

<< Previous
Bullboard Posts
Next >>